Found: 12
Select item for more details and to access through your institution.
The prognostic role of ephrin A2 and endothelial growth factor receptor pathway mediators in patients with advanced colorectal cancer treated with cetuximab.
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
Fatal Oxaliplatin-Induced Thrombotic Thrombocytopenic Purpura: A Case Report.
- Published in:
- Clinical Colorectal Cancer, 2013, v. 12, n. 4, p. 294, doi. 10.1016/j.clcc.2013.09.002
- By:
- Publication type:
- Article
Prognostic Factors in Relation to Racial Disparity in Advanced Colorectal Cancer Survival.
- Published in:
- Clinical Colorectal Cancer, 2013, v. 12, n. 4, p. 287, doi. 10.1016/j.clcc.2013.08.001
- By:
- Publication type:
- Article
Prognostic Value of the Combination of Circulating Tumor Cells Plus KRAS in Patients With Metastatic Colorectal Cancer Treated With Chemotherapy Plus Bevacizumab.
- Published in:
- Clinical Colorectal Cancer, 2013, v. 12, n. 4, p. 280, doi. 10.1016/j.clcc.2013.06.001
- By:
- Publication type:
- Article
Timeliness of Adjuvant Chemotherapy for Stage III Adenocarcinoma of the Colon: A Measure of Quality of Care.
- Published in:
- Clinical Colorectal Cancer, 2013, v. 12, n. 4, p. 275, doi. 10.1016/j.clcc.2013.08.002
- By:
- Publication type:
- Article
The Prognostic Role of Ephrin A2 and Endothelia Growth Factor Receptor Pathway Mediators in Patients With Advanced Colorectal Cancer Treated With Cetuximab.
- Published in:
- Clinical Colorectal Cancer, 2013, v. 12, n. 4, p. 267, doi. 10.1016/j.clcc.2013.07.001
- By:
- Publication type:
- Article
Clinical Significance of Long Intergenic Noncoding RNA-p21 in Colorectal Cancer.
- Published in:
- Clinical Colorectal Cancer, 2013, v. 12, n. 4, p. 261, doi. 10.1016/j.clcc.2013.06.003
- By:
- Publication type:
- Article
An Examination of Racial Differences in Process and Outcome of Colorectal Cancer Care Quality Among Users of the Veterans Affairs Health Care System.
- Published in:
- Clinical Colorectal Cancer, 2013, v. 12, n. 4, p. 255, doi. 10.1016/j.clcc.2013.06.004
- By:
- Publication type:
- Article
A Phase 1B Study of Dulanermin in Combination With Modified FOLFOX6 Plus Bevacizumab in Patients With Metastatic Colorectal Cancer.
- Published in:
- Clinical Colorectal Cancer, 2013, v. 12, n. 4, p. 248, doi. 10.1016/j.clcc.2013.06.002
- By:
- Publication type:
- Article
Axitinib or Bevacizumab Plus FOLFIRI or Modified FOLFOX-6 After Failure of First-Line Therapy for Metastatic Colorectal Cancer: A Randomized Phase II Study.
- Published in:
- Clinical Colorectal Cancer, 2013, v. 12, n. 4, p. 239, doi. 10.1016/j.clcc.2013.09.001
- By:
- Publication type:
- Article
Impact of Physical Activity After Cancer Diagnosis on Survival in Patients With Recurrent Colon Cancer: Findings From CALGB 89803/Alliance.
- Published in:
- Clinical Colorectal Cancer, 2013, v. 12, n. 4, p. 233, doi. 10.1016/j.clcc.2013.06.005
- By:
- Publication type:
- Article
Importance of Response to Neoadjuvant Therapy in Patients With Liver-Limited mCRC When the Intent Is Resection and/or Ablation.
- Published in:
- Clinical Colorectal Cancer, 2013, v. 12, n. 4, p. 223, doi. 10.1016/j.clcc.2013.06.006
- By:
- Publication type:
- Article